Skip to main content

Posts

Showing posts from May, 2021

Oxygen Concentrator Buying Guide Remember While Purchasing

 Oxygen Concentrator Buying Guide Remember While Purchasing देश में कोरोना वायरस से जंग जारी है और इस समय ऑक्सीजन कॉन्सन्ट्रेटर और ऑक्सीमीटर जैसे डिवाइसेज की जरूरत तेजी से बढ़ी है। राहत की बात है कि पिछले 24 घंटों में कोरोना के नए मामलों में कमी आई है। कोरोना के इस स्ट्रेन से संक्रमित लोगों में ऑक्सीजन लेवल में कमी देकी गई है। यही वजह है कि ऑक्सीजन कॉन्सन्ट्रेटर या जेनरेटर्स की डिमांड बढ़ गई है। आज हम आपको बताएंगे ऑक्सीजन कॉन्सन्ट्रेटर के बारे में सबकुछ। साथ ही जानेंगे कि इसे खरीदने से पहले किन बातों का ध्यान रखना जरूरी है। ऑक्सीजन कॉन्सन्ट्रेटर भी सिलिंडर की तरह ही काम करता है। लेकिन यह नैचरल हवा से ऑक्सीजन बनाता है और अनचाही गैस को रिमूव कर देता है। ऑक्सीजन को कॉन्सन्ट्रेट कर इससे एक पाइप के जरिए मरीज को प्योर ऑक्सीजन दी जा सकती है। सबसे खास बात है कि ये ऑक्सीजन कॉन्सन्ट्रेटर पोर्टेबल हैं और 24x7 काम कर सकते हैं। ध्यान रहे कि कोविड-19 से संक्रमित व्यक्ति को अगर सांस लेने में समस्या है तो वह कॉन्सन्ट्रेट का इस्तेमाल कर सकता है। कोविड के समय में बॉडी में ऑक्सीजन कॉन्सन्ट्रेशन की डि...

Chinese scientists discussed weaponising SARS coronaviruses 5 years before pandemic

Chinese scientists discussed weaponising SARS coronaviruses 5 years before pandemic: Report  China, May 9 (ANI): A document written by Chinese scientists and health officials before the pandemic in 2015 states that SARS coronaviruses were a "new era of genetic weapons" that could be "artificially manipulated into an emerging human disease virus, then weaponized and unleashed, reported Weekend Australian. The paper titled The Unnatural Origin of SARS and New Species of Man-Made Viruses as Genetic Bioweapons suggested that World War Three would be fought with biological weapons. The document revealed that Chinese military scientists were discussing the weaponization of SARS coronaviruses five years before the COVID-19 pandemic. The report by Weekend Australian was published in news.com.au. Peter Jennings, the executive director of the Australian Strategic Policy Institute (ASPI), told news.com.au that the document is as close to a "smoking gun" as we've got. ...

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

 Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable? Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections. At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision. In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight. The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is ...

DRDO's 2-DG Gets DCGI Approval | INMAS develops anti-covid therapeutic application of 2-deoxy-D-glucose drug

 DRDO's 2-DG Gets DCGI Approval | INMAS Develops Anti-Covid Therapeutic Application of 2-Deoxy-D-Glucose Drug The anti-COVID-19 therapeutic has been developed by DRDO scientists at the Institute of Nuclear Medicine and Allied Sciences (INMAS). The Drugs Controller General of India (DCGI), a body responsible for approval of licences of drugs in India, has approved the anti-COVID-19 therapeutic developed by Defence Ministry's  Defence Research and Development Organisation (DRDO). The drug, which received the emergency use authorisation on May 1, is called 2-deoxy-D-glucose (2-DG). According to a press release by the Defence Ministry, clinical trials of 2-DG have demonstrated that it helps in faster recovery of patients severely ill with the COVID-19 disease. The drug helps in faster recovery of hospitalised patients by reducing their dependency on oxygen, which can come in handy in these trying times when the country is suffering from an acute shortage of oxygen concentrators....